Home

perles lourd Susteen jean louis gassee theranos cloison Les municipalités Allergique

Billion Dollar Blood Test Startup Theranos: is it the next Enron? | by  Austin D Munday | Medium
Billion Dollar Blood Test Startup Theranos: is it the next Enron? | by Austin D Munday | Medium

Theranos CEO Elizabeth Holmes fires back at report attacking her company's  blood-testing tech | VentureBeat
Theranos CEO Elizabeth Holmes fires back at report attacking her company's blood-testing tech | VentureBeat

Theranos Response to WSJ Report
Theranos Response to WSJ Report

Theranos Trouble: A First Person Account | by Jean-Louis Gassée | Monday  Note
Theranos Trouble: A First Person Account | by Jean-Louis Gassée | Monday Note

Theranos CEO Elizabeth Holmes Punches Back Against The Wall Street Jou
Theranos CEO Elizabeth Holmes Punches Back Against The Wall Street Jou

Frederic Filloux on Twitter: ""Theranos Could Have Been Stopped" - Jean-Louis  Gassée @jlg https://t.co/Y5mPHxmghv https://t.co/Ufn5y1HuSh" / Twitter
Frederic Filloux on Twitter: ""Theranos Could Have Been Stopped" - Jean-Louis Gassée @jlg https://t.co/Y5mPHxmghv https://t.co/Ufn5y1HuSh" / Twitter

Theranos Trouble: A First Person Account | by Jean-Louis Gassée | Monday  Note
Theranos Trouble: A First Person Account | by Jean-Louis Gassée | Monday Note

Walgreens Puts The Brakes On Theranos Roll Out ‒ Are Lawsuits Next?
Walgreens Puts The Brakes On Theranos Roll Out ‒ Are Lawsuits Next?

Theranos Could Have Used a Few Short Sellers - Bloomberg
Theranos Could Have Used a Few Short Sellers - Bloomberg

Ex-Apple Exec Describes First-Hand Experience With Theranos Blood Tests |  Fortune
Ex-Apple Exec Describes First-Hand Experience With Theranos Blood Tests | Fortune

50 Years In Tech. Part 9: Mac Hopes And Troubles | by Jean-Louis Gassée |  Monday Note
50 Years In Tech. Part 9: Mac Hopes And Troubles | by Jean-Louis Gassée | Monday Note

Theranos – Monday Note
Theranos – Monday Note

Theranos mess: How it unfolded | Fortune
Theranos mess: How it unfolded | Fortune

Theranos CEO Elizabeth Holmes Goes on Stage at WSJDLive 2015 — Live Blog -  WSJ
Theranos CEO Elizabeth Holmes Goes on Stage at WSJDLive 2015 — Live Blog - WSJ

What We Really Know About Theranos
What We Really Know About Theranos

What We Really Know About Theranos
What We Really Know About Theranos

How a culture of secrecy set Theranos up for failure - Vox
How a culture of secrecy set Theranos up for failure - Vox

Theranos Could Have Been Stopped. by Jean-Louis Gassée | by Jean-Louis  Gassée | Monday Note
Theranos Could Have Been Stopped. by Jean-Louis Gassée | by Jean-Louis Gassée | Monday Note

Theranos Trouble: A First Person Account | by Jean-Louis Gassée | Monday  Note
Theranos Trouble: A First Person Account | by Jean-Louis Gassée | Monday Note

Theranos CEO Elizabeth Holmes Goes on Stage at WSJDLive 2015 — Live Blog -  WSJ
Theranos CEO Elizabeth Holmes Goes on Stage at WSJDLive 2015 — Live Blog - WSJ

Theranos, a Blood Testing Start-Up, Defends Its Accuracy - The New York  Times
Theranos, a Blood Testing Start-Up, Defends Its Accuracy - The New York Times

Theranos Response to WSJ Report
Theranos Response to WSJ Report

THE WALL STREET JOURNAL.
THE WALL STREET JOURNAL.

Quinn: Time for Theranos and Elizabeth Holmes to open up – The Mercury News
Quinn: Time for Theranos and Elizabeth Holmes to open up – The Mercury News

Theranos Trouble: A First Person Account | by Jean-Louis Gassée | Monday  Note
Theranos Trouble: A First Person Account | by Jean-Louis Gassée | Monday Note

Archive of stories about Theranos – Medium
Archive of stories about Theranos – Medium

How a culture of secrecy set Theranos up for failure - Vox
How a culture of secrecy set Theranos up for failure - Vox

Two FDA Inspection Reports Show Theranos' Blood-Collection 'Nanotainer' Was  an Uncleared Class II Medical Device - Dark Daily
Two FDA Inspection Reports Show Theranos' Blood-Collection 'Nanotainer' Was an Uncleared Class II Medical Device - Dark Daily